An extra allele of Chk1 limits oncogene-induced replicative stress and promotes transformation

被引:83
作者
Lopez-Contreras, Andres J. [1 ]
Gutierrez-Martinez, Paula [1 ]
Specks, Julia [1 ]
Rodrigo-Perez, Sara [1 ]
Fernandez-Capetillo, Oscar [1 ]
机构
[1] Spanish Natl Canc Res Ctr CNIO, Genom Instabil Grp, E-28029 Madrid, Spain
基金
欧洲研究理事会;
关键词
EARLY EMBRYONIC LETHALITY; DOUBLE-STRAND BREAKS; DNA-DAMAGE RESPONSE; ATAXIA-TELANGIECTASIA; GENOMIC INSTABILITY; SYNTHETIC LETHALITY; CANCER DEVELOPMENT; TUMOR SUPPRESSION; ADULT MICE; GENE ATR;
D O I
10.1084/jem.20112147
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Replicative stress (RS) is a type of endogenous DNA damage that cells suffer every time they duplicate their genomes, and which is further boosted by oncogenes. In mammals, the RS response (RSR) is coordinated by ATR and Chk1 kinases. We sought to develop a mammalian organism that is selectively protected from RS. To this end, mice carrying an extra copy of the Chk1 gene were generated. In vitro, Chk1 transgenic cells are protected from RS-inducing agents. Moreover, an extra Chk1 allele prolongs the survival of ATR-Seckel mice, which suffer from high levels of RS, but not that of ATM-deficient mice, which accumulate DNA breaks. Surprisingly, increased Chk1 levels favor transformation, which we show is associated with a reduction in the levels of RS induced by oncogenes. Our study provides the first example where supra-physiological levels of a tumor suppressor can promote malignant transformation, which is a result of the protection from the RS found in cancer cells.
引用
收藏
页码:455 / 461
页数:7
相关论文
共 31 条
  • [1] Atm-deficient mice: A paradigm of ataxia telangiectasia
    Barlow, C
    Hirotsune, S
    Paylor, R
    Liyanage, M
    Eckhaus, M
    Collins, F
    Shiloh, Y
    Crawley, JN
    Ried, T
    Tagle, D
    WynshawBoris, A
    [J]. CELL, 1996, 86 (01) : 159 - 171
  • [2] A continuum model for tumour suppression
    Berger, Alice H.
    Knudson, Alfred G.
    Pandolfi, Pier Paolo
    [J]. NATURE, 2011, 476 (7359) : 163 - 169
  • [3] Nucleotide Deficiency Promotes Genomic Instability in Early Stages of Cancer Development
    Bester, Assaf C.
    Roniger, Maayan
    Oren, Yifat S.
    Im, Michael M.
    Sarni, Dan
    Chaoat, Malka
    Bensimon, Aaron
    Zamir, Gideon
    Shewach, Donna S.
    Kerem, Batsheva
    [J]. CELL, 2011, 145 (03) : 435 - 446
  • [4] Brown EJ, 2000, GENE DEV, V14, P397
  • [5] ATR: an essential regulator of genome integrity
    Cimprich, Karlene A.
    Cortez, David
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2008, 9 (08) : 616 - 627
  • [6] ATR and ATRIP: Partners in checkpoint signaling
    Cortez, D
    Guntuku, S
    Qin, J
    Elledge, SJ
    [J]. SCIENCE, 2001, 294 (5547) : 1713 - 1716
  • [7] ATM regulates ATR chromatin loading in response to DNA double-strand breaks
    Cuadrado, M
    Martinez-Pastor, B
    Murga, M
    Toledo, LI
    Gutierrez-Martinez, P
    Lopez, E
    Fernandez-Capetillo, O
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2006, 203 (02) : 297 - 303
  • [8] Targeted disruption of the cell-cycle checkpoint gene ATR leads to early embryonic lethality in mice
    de Klein, A
    Muijtjens, M
    van Os, R
    Verhoeven, Y
    Smit, B
    Carr, AM
    Lehmann, AR
    Hoeijmakers, JHJ
    [J]. CURRENT BIOLOGY, 2000, 10 (08) : 479 - 482
  • [9] 'Super p53' mice exhibit enhanced DNA damage response, are tumor resistant and age normally
    García-Cao, I
    García-Cao, M
    Martín-Caballero, J
    Criado, LM
    Klatt, P
    Flores, JM
    Weill, JC
    Blasco, MA
    Serrano, M
    [J]. EMBO JOURNAL, 2002, 21 (22) : 6225 - 6235
  • [10] Combining ATR Suppression with Oncogenic Ras Synergistically Increases Genomic Instability, Causing Synthetic Lethality or Tumorigenesis in a Dosage-Dependent Manner
    Gilad, Oren
    Nabet, Barzin Y.
    Ragland, Ryan L.
    Schoppy, David W.
    Smith, Kevin D.
    Durham, Amy C.
    Brown, Eric J.
    [J]. CANCER RESEARCH, 2010, 70 (23) : 9693 - 9702